Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Juret

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal De Chirurgie|February 1, 1976
[Pregnancy and breast cancer: 2 entities with complex interferences. Critical study of the dossier]P Juret
Annales D'Anatomie Pathologique|January 1, 1978
[Stewart-Treves syndrome. Apropos of a case with ultrastructural study]A M Mandard, P Herlin, H Elie, et al.
Bulletin Du Cancer|April 1, 1975
[Age at the time of the first birth: a variable with simple, double, or triple significance in breast cancer studies]P Juret, J E Couette, D Brune, et al.
Bulletin Du Cancer|January 1, 1981
[Hydroxy-9-methyl-2-ellipticinium (NSC 264-137) for osseous metastases from breast cancer. A 4 year experience (author's transl)]P Juret, J E Couette, T Delozier, et al.
Cancer Treatment Reports|November 1, 1982
Hydroxy-9-methyl-2-ellipticinium for osseous metastases from breast cancer: a 5-year experienceP Juret, J F Heron, J E Couette, et al.
Lancet (London, England)|February 25, 1978
Sex of first child as a prognostic factor in breast cancerP Juret, J E Couette, T Delozier, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137)C Paoletti, J B Le Pecq, N Dat-Xuong, et al.
Breast Cancer Research and Treatment|January 1, 1986
Adjuvant tamoxifen in postmenopausal breast cancer: preliminary results of a randomized trialT Delozier, J P Julien, P Juret, et al.
Presse Medicale (Paris, France : 1983)|June 4, 1983
[Reliability of cytologic puncture. Who should perform the puncture of breast tumors?]E de Ranieri, A M Mandard, P Juret, et al.
La Nouvelle Presse Medicale|April 21, 1979
[Hydroxy 9-methyl 2-ellipticinium acetate (NSC 264-137). Toxicologic study and therapeutic effect in 100 cancers (author's transl)]P Juret, A Tanguy, A Girard, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal De Chirurgie|February 1, 1976
[Pregnancy and breast cancer: 2 entities with complex interferences. Critical study of the dossier]P Juret
Annales D'Anatomie Pathologique|January 1, 1978
[Stewart-Treves syndrome. Apropos of a case with ultrastructural study]A M Mandard, P Herlin, H Elie, et al.
Bulletin Du Cancer|April 1, 1975
[Age at the time of the first birth: a variable with simple, double, or triple significance in breast cancer studies]P Juret, J E Couette, D Brune, et al.
Bulletin Du Cancer|January 1, 1981
[Hydroxy-9-methyl-2-ellipticinium (NSC 264-137) for osseous metastases from breast cancer. A 4 year experience (author's transl)]P Juret, J E Couette, T Delozier, et al.
Cancer Treatment Reports|November 1, 1982
Hydroxy-9-methyl-2-ellipticinium for osseous metastases from breast cancer: a 5-year experienceP Juret, J F Heron, J E Couette, et al.
Lancet (London, England)|February 25, 1978
Sex of first child as a prognostic factor in breast cancerP Juret, J E Couette, T Delozier, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137)C Paoletti, J B Le Pecq, N Dat-Xuong, et al.
Breast Cancer Research and Treatment|January 1, 1986
Adjuvant tamoxifen in postmenopausal breast cancer: preliminary results of a randomized trialT Delozier, J P Julien, P Juret, et al.
Presse Medicale (Paris, France : 1983)|June 4, 1983
[Reliability of cytologic puncture. Who should perform the puncture of breast tumors?]E de Ranieri, A M Mandard, P Juret, et al.
La Nouvelle Presse Medicale|April 21, 1979
[Hydroxy 9-methyl 2-ellipticinium acetate (NSC 264-137). Toxicologic study and therapeutic effect in 100 cancers (author's transl)]P Juret, A Tanguy, A Girard, et al.
Pageof 2